Media-OutReach Newswire Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
Media-OutReach Newswire DHL Express helps global law firm Linklaters cut carbon emissions using sustainable aviation fuel
Media-OutReach Newswire Neurum’s digital intervention achieves 95% effectiveness in boosting employees’ wellbeing